HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine: a preliminary study.

AbstractBACKGROUND:
The aims of this preliminary study were to determine the alteration of serum ischemia-modified albumin (IMA) levels and to investigate whether IMA may be used as an indicator of the cardioprotective efficacy of N-acetylcysteine (NAC) in patients undergoing coronary bypass grafting (CABG).
PATIENTS AND METHODS:
Forty-four patients were randomized into one of two groups on the basis of cardioplegic strategies, either cold-blood cardioplegia enriched with NAC (50 mg/kg) or cold-blood cardioplegia alone. Serum IMA, cardiac troponin T (cTnT) and malondialdehyde (MDA) levels determined in NAC-enriched patients before and after CABG were compared with those of the NAC-free group. The albumin cobalt binding assay was used for IMA determination.
RESULTS:
Serum IMA levels were significantly elevated after cross-clamping and peaked at 6 h after reperfusion in the two groups. In NAC-enriched patients, IMA levels determined 6, 12, 24 and 48 h after reperfusion were significantly lower than those of the NAC-free group (p < or = 0.001, p < 0.001, p < 0.001 and p < 0.001, respectively). IMA returned to baseline 24 h after reperfusion differently from cTnT and MDA in the NAC-enriched group.
CONCLUSIONS:
IMA may be used as not only an indicator of myocardial ischemia-reperfusion injury, but also as a useful indicator of the cardioprotective effect of NAC in CABG.
AuthorsS Caner Karahan, Ismail Koramaz, Gokalp Altun, Utku Uçar, Murat Topbaş, Ahmet Menteşe, Muge Kopuz
JournalEuropean surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes (Eur Surg Res) Vol. 44 Issue 1 Pg. 30-6 ( 2010) ISSN: 1421-9921 [Electronic] Switzerland
PMID19955769 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
CopyrightCopyright 2009 S. Karger AG, Basel.
Chemical References
  • Albumins
  • Cardiotonic Agents
  • Troponin T
  • Malondialdehyde
  • Acetylcysteine
Topics
  • Acetylcysteine (therapeutic use)
  • Albumins (metabolism)
  • Cardiotonic Agents (therapeutic use)
  • Cold Temperature
  • Coronary Artery Bypass (adverse effects)
  • Female
  • Heart Arrest, Induced (adverse effects)
  • Humans
  • Male
  • Malondialdehyde
  • Middle Aged
  • Myocardial Reperfusion Injury (blood, etiology, prevention & control)
  • Troponin T (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: